In this study, we observed that in COVID-19 patients, severe eosinopenia was associated with elevated circulating concentrations of IP-10, an inflammatory chemokine whose levels have been strongly associated with ARDS occurrence [20]. Here, CXCL10 is linked to COVID-19.